Plasmablastic lymphoma (PBL) is an aggressive lymphoma commonly associated with HIV
infection. However, PBL can also be seen in patients with other immunodeficiencies as well …

Plasmablastic lymphoma (PbL) is a rare and aggressive B-cell malignancy with large
neoplastic cells, most of them resembling plasmablasts that have a CD20-negative …

Plasmablastic lymphoma (PBL) is a highly aggressive B cell non‐Hodgkin lymphoma
frequently associated with immunosuppression, particularly human immunodeficiency virus …

Patients infected with human immunodeficiency virus (HIV) are at increased risk for
developing both non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). Even if this …

Plasmablastic lymphoma (PBL) is a challenging diagnosis given its rarity and lack of
expression of markers that are usually used by pathologists in establishing hematopoietic …

Simple Summary Epstein–Barr virus (EBV) is involved in lymphomagenesis, especially
lymphomas affecting populations with immunodeficiencies, such as people living with HIV …

BLOOD RESEARCH Page 1 This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) …

HIV-associated PBL is an AIDS-defining cancer, classified by WHO as a distinct entity of
aggressive DLBCL. To date less than 250 cases have been published, of them 17 are …

Plasmablastic lymphoma (PBL) is a rare entity, commonly associated with
immunosuppressed states such as human immunodeficiency virus (HIV) infection or solid …

Simple Summary Epstein–Barr virus (EBV)-associated lymphoproliferative disorders have
been garnering attention in recent years. EBV infects people primarily in their first years of …